CORRESP 1 filename1.htm

 

SELLAS Life Sciences Group, Inc.

15 West 38th St., 10th Floor

New York, New York 10018

 

October 9, 2019

 

VIA EDGAR

 

United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

 

     
RE:  

SELLAS Life Sciences Group, Inc.
Registration Statement on Form S-3/A

Commission File No. 333- 233869
Acceleration Request

     

Ladies and Gentlemen:

 

Pursuant to Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, SELLAS Life Sciences Group, Inc. (the “Company”) hereby respectfully requests that the effectiveness of the above-captioned Registration Statement on Form S-3 be accelerated to Friday, October 11, 2019, at 4:30 p.m. Eastern Time, or as soon as practicable thereafter.

 

The Company acknowledges that:

 

  •   should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 

  •   the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 

  •   the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 

The cooperation of the staff in meeting the timetable described above is very much appreciated.

 

Any questions regarding this request should be addressed to Daniel A. Bagliebter, Esq., at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., 666 Third Avenue, New York, New York, 10017, telephone (212) 692-6856.

 

  Very truly yours,
   
  SELLAS Life Sciences Group, Inc.
   
  /s/ Angelos M. Stergiou                                    
  By:  Angelos M. Stergiou, M.D., Sc.D., h.c.
  Its:  President and Chief Executive Officer

 

cc:Cliff M. Silverman, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.